Descrição

Acne is a skin condition that occurs when your hair follicles become plugged with oil and dead skin cells. It causes whiteheads, blackheads or pimples. Acne is most common among teenagers, though it affects people of all ages. De acordo com um relatório da StrategyHelix, the global acne treatment market is set to increase by US$ 2,242.4 milhões durante 2022-2028, crescendo em um CAGR de 5.1% durante o período de previsão.

O relatório fornece dados atualizados sobre o tamanho do mercado para o período 2018-2021 e previsão para 2028 covering key market aspects like sales value for acne treatment. The global acne treatment market is segmented on the basis of treatment, acne type, usuário final, and region. On the basis of treatment, the global acne treatment market has been segmented into medication, therapeutic devices. The medication segment is estimated to account for the largest share of the global acne treatment market. By acne type, the global acne treatment market has been segmented into moderate, mild, moderate to severe. Based on end user, the global acne treatment market is categorized into hospitals & clínicas, specialty centers. Geographically, the global acne treatment market is segmented into North America, Ásia-Pacífico, Europa, Rest of the World (ROW).

The medication market is further segmented into retinoids, antibiotics, hormonal agents, e outros. Além disso, the medication by drug type market has been categorized into OTC, and prescription. The medication by route of administration market is further divided into topical, oral, and injectable. The therapeutic devices market is further segmented into laser treatment, and microdermabrasion.

The global acne treatment market is highly competitive. Key companies profiled in the report include Allergan plc, Almirall S.A., Bausch Health Companies Inc., F. Hoffmann-la Roche Ltd., Galderma S.A. (Nestlé S.A.), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Mylan N.V., Perrigo Company plc, Pfizer Inc., Teva Pharmaceutical Industries Ltd.

O relatório é um recurso inestimável para empresas e organizações ativas neste setor. It provides a cohesive picture of the acne treatment market to help drive informed decision making for industry executives, decisores políticos, acadêmico, e analistas.

Escopo do relatório

Treatment: medication, therapeutic devices
Acne type: moderate, mild, moderate to severe
Usuário final: hospitais & clínicas, specialty centers
Região: América do Norte, Ásia-Pacífico, Europa, Rest of the World (ROW)
Anos considerados: este relatório cobre o período 2018 para 2028

Principais benefícios para as partes interessadas

– Get a comprehensive picture of the global acne treatment market
– Identifique setores de crescimento e tendências para investimento

Índice

Papel 1. Introdução
– Escopo do estudo
– Período de estudos
– Escopo geográfico
– Metodologia de Pesquisa
Papel 2. Acne treatment market overview
Papel 3. Market breakdown by treatment
– Medication
– Therapeutic devices
Papel 4. Market breakdown by acne type
– Moderado
– Mild
– Moderate to severe
Papel 5. Detalhamento do mercado por usuário final
– Hospitais & clínicas
– Specialty centers
Papel 6. Market breakdown by region
– América do Norte
– Ásia-Pacífico
– Europa
– Rest of the World (ROW)
Papel 7. Principais empresas
– Allergan plc
– Almirall, S.A..
– Bausch Health Companies Inc.
– F. Hoffmann-la Roche Ltd.
– Galderma S.A. (Nestlé S.A.)
– GlaxoSmithKline Plc (GSK)
– Johnson & Johnson
– Mylan N.V.
– Perrigo Company plc
– Pfizer Inc.
– Teva Pharmaceutical Industries Ltd.
Sobre StrategyHelix
Isenção de responsabilidade